ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 636859 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 636859; 2) Community: the network communities that were significantly associated with the response to NSC 636859; 3) Molecule: the relationships between components within communities and NSC 636859; 4) MDR: the compounds that were significantly associated with the NSC 636859.

NSC Compound Enrichment Correlation
NSC 747292 Null 0.000930692338491031 0.21454598
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.000931492155975099 0.29470356
NSC 666787 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate 0.000931492155975099 0.28544468
NSC 674276 Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- 0.000931492155975099 -0.47881289
NSC 677640 Null 0.000931492155975099 -0.50112409
NSC 681104 Phosphonic acid, [1,4,7,10-tetraazacyclododecane-1,7-diylbis(methylene)]bis- 0.000931492155975099 0.5038345
NSC 759016 Null 0.000931492155975099 0.46941859
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.000931492155975102 0.54604147
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.000931492155975102 0.34712831
NSC 617989 3-Deazaneplanocin, hydrochloride 0.00119931827492064 0.53765262
Total:102  Current:5    [First] [Prev] [Next] [Last]